Ganciclovir and the treatment of Epstein-Barr virus hepatitis

L.A. Adams, B. Deboer, Bastiaan De Boer, Gary Jeffrey, R. Marley, G. Garas

Research output: Contribution to journalReview article

33 Citations (Scopus)

Abstract

Epstein-Barr virus (EBV) is part of the herpesvirus family that infects up to 90% of the population. Initial infection is often subclincal in children but will generally result in symptomatic infectious mononucleosis in adolescents and adults. Ganciclovir has been utilized in immunocompromised patients with EBV encephalitis and post-liver transplant for EBV fulminant hepatitis. Herein, the successful use of ganciclovir in two immunocompetent patients with severe EBV hepatitis is reported.
Original languageEnglish
Pages (from-to)1758-1760
JournalGastroenterology & Hepatology
Volume21
DOIs
Publication statusPublished - 2006

    Fingerprint

Cite this